Nyxoid
What it is used for
Nyxoid is intended as part of the emergency treatment for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in:, the home or other non medical setting, a health facility setting,For this reason, Nyxoid should be carried by persons at risk of, or likely to witness such events.,Nyxoid is indicated in adults and children.
How to take it
The way to take this medicine is: Nasal. This medicine is given through the nose and absorbed through the nasal passages.
- Store below 30 degrees Celsius
- Do not Freeze
- Shelf lifetime is 30 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
The way to take this medicine is: Nasal. This medicine is given through the nose and absorbed through the nasal passages.
- Store below 30 degrees Celsius
- Do not Freeze
- Shelf lifetime is 30 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient naloxone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Do I need a prescription?
This medicine is available from a pharmacy without prescription. It is
Visual appearance
A unit dose device containing a vial held tightly within a vial holder. The vial is a clear glass vial containing liquid and a black stopper. All components show no visible signs of damage.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.